Age Well
As science reveals distinct biological “bursts” in aging, longevity interventions start targeting critical acceleration points.
Research shows 40% of aging occurs during biological transitions at 44 and 60, demanding new approaches from the $600B longevity market, per BoA.
Advanced diagnostic platforms will combine epigenetic testing, mitochondrial function analysis, and hormone optimization to combat and reverse decline.
Like a “GPS for aging,” next-gen longevity solutions will navigate users through distinct life phases.